AR037097A1 - Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento - Google Patents
Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamentoInfo
- Publication number
- AR037097A1 AR037097A1 ARP020103736A ARP020103736A AR037097A1 AR 037097 A1 AR037097 A1 AR 037097A1 AR P020103736 A ARP020103736 A AR P020103736A AR P020103736 A ARP020103736 A AR P020103736A AR 037097 A1 AR037097 A1 AR 037097A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- cycloalkyl
- phenyl
- substituents
- defined above
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Abstract
Un compuesto acilsulfonamidas de fórmula (1), en donde: R1 es haloalquilo C1-6, alquenilo C2-6, alquenilo C2-6 substituido por fenilo, no substituido o substituido por 1 hasta 5 sustituyentes, tienilo, piridina, benztiazolilo, cromanilo (esto es, 1,2-dihidrobenzopiranilo) o arilo C6-18, en donde los sustituyentes son seleccionados del grupo que consiste de halógeno, nitro, di-alquilamino C1-4, ciano, alquilo C1-6, haloalquilo C1-4, fenilcarbonilamino-alquilo C1-4 no sustituido, alcoxi C1-4, haloalcoxi C1-4, aminocarbonilo, di-alquilaminocarbonilo C1-4, alquilcarbonilo C1-4, alcoxicarbonilo C1-4, fenilo no sustituido, carboxilo y fenilcarbonilamino-alquilo C1-4 sustituido por fenilo o fenilo sustituido, en donde los sustituyentes fenilo son seleccionados del grupo que consiste de halógeno, nitro, di-alquilamino C1-4, ciano, alquilo C1-6, haloalquilo C1-4, alcoxi C1-4, haloalcoxi C1-4, aminocarbonilo, di-alquilaminocarbonilo C1-4, alquilcarbonilo C1-4, alcoxicarbonilo C1-4 y carboxilo, o R1 se selecciona del grupo de fórmulas (2); R2 se selecciona del grupo de fórmulas (3); R3 y R13 independientemente de cada uno son hidrógeno, hidroxi, halógeno, ciano, alquilo C1-4, alcoxi C1-4, fenilo o fenoxi, al menos uno de R4 y R5 junto con el átomo de carbono al cual están enlazados, R11 y R12 juntos con el átomo de carbono al cual están enlazados, independientemente de cada uno son un sustituido, sistema cicloalquilo de conexión, cicloalquilo C4-8, piperidina, tetrahidropiridina, o sistema heterocíclico de conexión, en donde los sustituyentes son seleccionados del grupo que consiste de alcoxicarbonilamino C1-6, alcoxicarbonil C1-6-(alquil C1-4)amino, alcoxicarbonil C1-6-(alquenil C2-4)amino, cicloalquilcarbonilamino C3-8, cicloalquilcarbonil C3-8-(alquil C1-4)amino, cicloalquilcarbonil C3-8-(alquenil C2-4)amino, alcoxicarboniloxi C1-6, fenil-alquilcarboniloxi C1-4, en donde fenilo está no sustituido o sustituido y en donde los sustituyentes son como se definió arriba por fenilo sustituido, fenilsulfonilo, en donde fenilo está no sustituido o sustituido y en donde los sustituyentes son como se definió arriba por fenilo sustituido, alquilo C4-8, por ejemplo, alquilo C5-8, hidroxialquilo C1-4, hidroxialquilo C1-4 sustituido por fenilo, en donde fenilo está no sustituido o sustituido y en donde los sustituyentes son como se definió arriba por fenilo sustituido, alcoxicarbonil C1-6-alquilo C1-4, cicloalcoxicarbonil C3-8-alquilo C1-4, alcoxicarbonilamino C1-6-alquilo C1-4, cicloalquilcarbonilamino C3-8-alquilo C1-4, fenilo o fenilo sustituido, en donde los sustituyentes son como se definió arriba por fenilo sustituido, heterociclilo que tiene 5 o 6 miembros en el anillo y 1 hasta 4 heteroátomos seleccionados de N, O, S, por ejemplo, oxadiazolilo, cicloalcoxicarbonilo C3-8, cicloalquil C3-8-alquilcarbonilo C1-4, en donde cicloalquilo está no sustituido o sustituido por hidroxi, fenilcarbonilo, en donde fenilo está no sustituido o sustituido y en donde los sustituyentes son como se definió arriba por fenilo sustituido, cicloalquilaminocarbonilo C3-8, cicloalquil C3-8-(alquil C1-4)aminocarbonilo, cicloalquil C3-8(alquenil C2-4)aminocarbonilo, y alcoxicarbonilo C1-8); R3, R8, R13 y R18 independientemente de cada uno son hidrógeno, hidroxi, halógeno, ciano, alquilo C1-4, alcoxi C1-4, fenilo o fenoxi, ya sea R8 o R18, respectivamente, independientemente de cada uno son hidrógeno, hidroxi, halógeno, ciano, alquilo C1-4, alcoxi C1-4, fenilo o fenoxi, y al menos uno de R9 y R10 junto con el átomo de carbono al cual están enlazados, R16 y R17 junto con el átomo de carbono al cual están enlazados, independientemente de cada uno tiene el significado de R4 y R5 junto con el átomo de carbono al cual están enlazados, como se definió arriba, o al menos uno de R9 y R10 juntos con el átomo de carbono al cual están enlazados, R16 y R17 juntos con el átomo de carbono al cual están enlazados, son cicloalquilo C3-8, y R8 o R18, respectivamente, independientemente de cada uno son un sustituido, sistema cicloalquilo de conexión, cicloalquilo C4-8, piperidina sustituida, tetrahidropiridina, o un sistema heterocíclico de conexión, en donde los sustituyentes son como se definió arriba para los grupos correspondientes, R6 y R15 independientemente de cada uno son haloalquilo C1-6, arilo C6-18 no sustituido o sustituido, en donde los sustituyentes arilo son como se definió arriba, o un sustituido, sistema cicloalquilo de conexión, cicloalquilo C4-8, piperidina, tetrahidropiridina, o sistema heterocíclico de conexión, en donde los sustituyentes son como se definió arriba para los grupos correspondientes o R6 y R15 independientemente de cada uno son amino sustituido por un sustituido sistema cicloalquilo de conexión, cicloalquilo C4-8, piperidina, tetrahidropiridina, o sistema heterocíclico de conexión, en donde los sustituyentes son como se definió arriba para el grupo correspondiente, R7 y R14 independientemente de cada uno son un sustituido sistema cicloalquilo de conexión, cicloalquilo C4-8, piperidina, tetrahidropiridina, o sistema heterocíclico de conexión, en donde los sustituyentes son como se definió arriba para los grupos correspondientes, o R7 y R14 independientemente de cada uno son amino sustituido por un sustituido sistema cicloalquilo de conexión, cicloalquilo C4-8, piperidina, tetrahidropiridina, o sistema heterocíclico de conexión, en donde los sustituyentes son como se definió arriba para el grupo correspondiente, m es 0, 1, 2, 3 ó 4, tal como 0 ó 1, n es 0, 1, 2, 3, ó 4, tal como 0 ó 1, y si m y/o n son diferentes a 0, entonces R1, si m es diferente a 0 y R2, n es diferente a 0, independientemente del otro tiene el significado como se define arriba, y adicionalmente puede ser piperazina sustituida, en donde los sustituyentes son como se definió arriba para piperidina sustituida; y un sistema cicloalquilo de conexión sustituido está sustituido como se definió arriba para un sistema cicloalquilo de conexión sustituido, y adicionalmente puede estar sustituido por oxo y/o alquilo C1-4; y si R1 es un sustituido sistema de anillo cicloalquilo de conexión, cicloalquilo C4-8, piperidina, tetrahidropiridina, o un sistema de anillo heterociclilo de conexión, en donde, los sustituyentes son como se definió arriba para los grupos correspondientes ,o si R1 es adicionalmente piperazina, si m es diferente a 0, entonces R2 tiene el significado como se definió arriba y adicionalmente puede ser haloalquilo C1-6, alquenilo C2-6 no sustituido, alquenilo C2-6 sustituido por fenilo, no sustituido o por 1 hasta 5 sustituyentes sustituido, tienilo, piridina, benztiazolilo, cromanilo (esta es, 1,2-dihidrobenzopiranilo) o arilo(C6-18), en donde los sustituyentes son como se definió arriba para los grupos correspondientes, y si m es 0, n es 0 y R2 es sustituido cicloalquilo C4-8 o un sistema de anillo sustituido de conexión en donde los sustituyentes son como se definieron arriba, entonces R1 es otro haloalquilo C1-6; composiciones farmacéuticas y el uso de dichos compuestos para la preparación de medicamentos para el tratamiento de padecimientos mediados por la acción de la sulfatasa esteroide.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0124028A GB0124028D0 (en) | 2001-10-05 | 2001-10-05 | Organic compounds |
GB0124027A GB0124027D0 (en) | 2001-10-05 | 2001-10-05 | Organic compounds |
GB0124839A GB0124839D0 (en) | 2001-10-16 | 2001-10-16 | Organic compounds |
GB0127173A GB0127173D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
GB0127174A GB0127174D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
GB0127343A GB0127343D0 (en) | 2001-11-14 | 2001-11-14 | Organic compounds |
GB0211524A GB0211524D0 (en) | 2002-05-20 | 2002-05-20 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR037097A1 true AR037097A1 (es) | 2004-10-20 |
Family
ID=27562601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020103736A AR037097A1 (es) | 2001-10-05 | 2002-10-03 | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento |
Country Status (17)
Country | Link |
---|---|
US (1) | US7482462B2 (es) |
EP (2) | EP2228364A1 (es) |
JP (1) | JP4390559B2 (es) |
KR (2) | KR20090123988A (es) |
CN (1) | CN100509774C (es) |
AR (1) | AR037097A1 (es) |
AU (1) | AU2002350490B2 (es) |
BR (1) | BR0213131A (es) |
CA (1) | CA2458453A1 (es) |
CO (1) | CO5570700A2 (es) |
HU (1) | HUP0401687A3 (es) |
IL (1) | IL160786A0 (es) |
MX (1) | MXPA04003236A (es) |
NZ (1) | NZ532072A (es) |
PE (1) | PE20030548A1 (es) |
PL (1) | PL367411A1 (es) |
WO (1) | WO2003031397A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100467449C (zh) | 2003-05-21 | 2009-03-11 | Aska制药株式会社 | 氨基磺酸环状氨基苯基酯衍生物 |
US20080096922A1 (en) * | 2004-04-06 | 2008-04-24 | Dainippon Sumitomo Pharma Co., Ltd. | Novel Sulfonamide derivative |
WO2005117882A2 (en) * | 2004-04-20 | 2005-12-15 | Incyte Corporation | Hydroxamic acid derivatives as metalloprotease inhibitors |
DE102004035203A1 (de) | 2004-07-21 | 2006-02-16 | Bayer Healthcare Ag | Substituierte Chinolone |
US20090227555A2 (en) * | 2005-01-06 | 2009-09-10 | Astrazeneca Ab | Novel Pyridine Compounds |
GB0505539D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
GB0505541D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
US7208526B2 (en) * | 2005-05-20 | 2007-04-24 | Hoffmann-La Roche Inc. | Styrylsulfonamides |
CA2614726A1 (en) * | 2005-07-13 | 2007-01-18 | Astrazeneca Ab | New pyridine analogues |
WO2007051255A1 (en) * | 2005-11-04 | 2007-05-10 | The University Of Sydney | Process for the preparation of compounds containing an azacyclic ring system |
DE102006005861A1 (de) | 2006-02-09 | 2007-08-23 | Aicuris Gmbh & Co. Kg | Substituierte Chinolone III |
JP5543920B2 (ja) | 2007-09-17 | 2014-07-09 | プレグレム エスアー | 閉経前の女性におけるエストロゲン依存症状の治療 |
LT3578547T (lt) | 2015-02-16 | 2021-08-25 | The University Of Queensland | Sulfonilkarbamidai ir giminingi junginiai bei jų panaudojimas |
US11465992B2 (en) | 2017-07-07 | 2022-10-11 | Inflazome Limited | Sulfonamide carboxamide compounds |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH402844A (de) | 1960-05-25 | 1965-11-30 | Ciba Geigy | Verfahren zur Herstellung neuer Sulfonamide |
US3534049A (en) * | 1968-04-12 | 1970-10-13 | American Home Prod | 1 - substituted - 3 - (1 - hydroxy - n - (arylsulfonyl)formimidoyl)pyridines and derivatives |
DE2004327A1 (de) | 1969-02-14 | 1970-09-03 | F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) | Bornanocarboxamide |
US3637845A (en) * | 1969-04-14 | 1972-01-25 | Minnesota Mining & Mfg | Fluoroalkanesulfonamides |
US3707559A (en) * | 1971-05-14 | 1972-12-26 | Searle & Co | N-acyl phenylalanine amides |
US3917692A (en) | 1974-06-12 | 1975-11-04 | Mead Johnson & Co | Arylsulfonylcarbamoyl-1,3-dicarbonylalicyclic |
GB1570536A (en) | 1976-03-01 | 1980-07-02 | Shell Int Research | Insecticidal substituted acetamides |
US4034091A (en) * | 1976-05-10 | 1977-07-05 | Shell Oil Company | N-(Arylsulfonyl)-2-nitro-2-(tetrahydro-2H-1,3-thiazin-2-ylidene)acetamides |
GB1576120A (en) | 1976-06-07 | 1980-10-01 | Shell Int Research | Method of treating rice |
US4029791A (en) | 1976-06-17 | 1977-06-14 | Shell Oil Company | N-(Arylsulfonyl)-2-nitro-2-(1-methyl-2-(1,3-diazacycloalkylidene)acetamides |
CA1092606A (en) * | 1976-10-05 | 1980-12-30 | Herbert Berger | 1-(n-acylcarbamoyl)-2-cyano-aziridines and the preparation thereof |
GB1593609A (en) * | 1978-01-31 | 1981-07-22 | Christiaens Sa A | Pyridine sulfonamides |
AU527371B2 (en) | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
DK101683A (da) * | 1982-03-12 | 1983-09-13 | Duphar Int Res | Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf |
US4743290A (en) | 1986-04-21 | 1988-05-10 | E. I. Du Pont De Nemours And Company | Thiophenesulfonamide herbicides |
US5085684A (en) * | 1988-05-09 | 1992-02-04 | Bayer Aktiengesellschaft | Herbicidal sulphonylaminocarbonyltriazolinones having substituents which are bonded via sulphur |
US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
US5300480A (en) * | 1989-04-13 | 1994-04-05 | Bayer Aktiengesellschaft | Herbicidal sulphonylaminocarbonyltriazolinones having two substituents bonded via oxygen |
US5057144A (en) * | 1988-05-09 | 1991-10-15 | Bayer Aktiengesellschaft | Sulphonylaminocarbonyltriazolinones |
DE3826230A1 (de) * | 1988-08-02 | 1990-02-08 | Hoechst Ag | Heterocyclische n-acylsufonamide, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als herbizide oder wachstumsregulatoren |
KR0138528B1 (en) | 1988-12-14 | 1998-05-01 | Shionogi Seiyaku Kk | Preparation of 2,3-trans-1,4-bridged cyclohexane sulfonamide derivatives |
CA2016710A1 (en) | 1989-05-15 | 1990-11-15 | Prasun K. Chakravarty | Substituted benzimidazoles as angiotensin ii antagonists |
IL94390A (en) | 1989-05-30 | 1996-03-31 | Merck & Co Inc | The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them |
EP0412594B1 (en) | 1989-07-28 | 1996-01-03 | Merck & Co. Inc. | Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
US5411980A (en) * | 1989-07-28 | 1995-05-02 | Merck & Co., Inc. | Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
DE3935277A1 (de) * | 1989-10-24 | 1991-05-02 | Hoechst Ag | Sulfonierte heterocyclische carboxamide, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als herbizide oder wachstumsregulatoren |
US5256632A (en) * | 1990-05-30 | 1993-10-26 | Bayer Aktiengesellschaft | Herbicidal sulphonylated carboxamides |
GB9015916D0 (en) | 1990-07-19 | 1990-09-05 | Schering Agrochemicals Ltd | Herbicides |
DE4029753A1 (de) * | 1990-09-20 | 1992-03-26 | Basf Ag | Sulfonamide |
JP2896822B2 (ja) * | 1990-11-29 | 1999-05-31 | キヤノン株式会社 | 非磁性一成分系現像剤、画像形成方法、画像形成装置、装置ユニット及びファクシミリ装置 |
DE4200954A1 (de) * | 1991-04-26 | 1992-10-29 | Bayer Ag | Heterocyclisch substituierte phenylessigsaeurederivate |
GB2263637A (en) * | 1992-01-28 | 1993-08-04 | Merck & Co Inc | Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists |
US5204354A (en) * | 1992-02-14 | 1993-04-20 | Merck & Co., Inc. | Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders |
US5356926A (en) | 1992-02-24 | 1994-10-18 | Warner-Lambert Company | 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo [β]thiophene-2-carboxamides as inhibitors of cell adhesion |
FR2694295B1 (fr) * | 1992-07-28 | 1994-09-02 | Adir | Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent. |
IL109431A (en) | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
DE4326344A1 (de) | 1993-08-05 | 1995-02-09 | Thomae Gmbh Dr K | Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
WO1995009151A1 (en) | 1993-09-28 | 1995-04-06 | Ciba-Geigy Ag | Acylated sulphonamides as insecticides and acaricides |
US5568872A (en) | 1994-09-13 | 1996-10-29 | Hinnant, Sr.; Wayne M. | Eyeglass holder |
DE4432860A1 (de) * | 1994-09-15 | 1996-03-21 | Merck Patent Gmbh | Imidazopyridine |
AU3642795A (en) | 1994-09-27 | 1996-04-19 | Merck & Co., Inc. | Endothelin receptor antagonists for the treatment of emesis |
JPH08208632A (ja) | 1994-10-28 | 1996-08-13 | Wakunaga Pharmaceut Co Ltd | 新規スルホンアミド誘導体又はその塩及びこれを含有する血圧降下剤 |
AU1106195A (en) | 1994-11-09 | 1996-06-06 | Novo Nordisk A/S | Heterocyclic compounds, their preparation and use |
HUP9602977A3 (en) | 1995-02-28 | 1998-01-28 | Daiichi Asubio Pharma Co Ltd | Arylpiperidine and arylpiperazine derivatives and drugs containing the same |
CA2218716A1 (en) | 1995-04-21 | 1996-10-24 | Novartis Ag | N-aroylamino acid amides as endothelin inhibitors |
JPH11504013A (ja) | 1995-04-21 | 1999-04-06 | イーライ・リリー・アンド・カンパニー | 新規な塩基性側鎖を有するベンゾチオフェン |
US5936089A (en) | 1995-05-29 | 1999-08-10 | Pfizer Inc | Dipeptides which promote release of growth hormone |
CN1192140A (zh) | 1995-08-04 | 1998-09-02 | 沃尼尔·朗伯公司 | 氨基磺酸衍生物、酰基磺酰氨或磺酰基氨基甲酸酯在制备降低脂蛋白水平的药物中的用途 |
US5798356A (en) | 1995-08-07 | 1998-08-25 | Alcon Laboratories, Inc. | Angiostatic compounds |
DE19540737A1 (de) * | 1995-11-02 | 1997-05-07 | Bayer Ag | Substituierte Sulfonylamino(thio)carbonylverbindungen |
ATE408607T1 (de) | 1996-04-12 | 2008-10-15 | Searle Llc | Substituierte benzensulfonamid-derivate als wirkstoff-vorläufer von cox-2 inhibitoren |
GB9609641D0 (en) | 1996-05-09 | 1996-07-10 | Pfizer Ltd | Compounds useful in therapy |
DE19650196A1 (de) * | 1996-12-04 | 1998-06-10 | Bayer Ag | Thienylsulfonylamino(thio)carbonylverbindungen |
US6013662A (en) * | 1996-12-30 | 2000-01-11 | Rhone-Poulenc Rorer S.A. | Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments |
DE19710831A1 (de) | 1997-03-15 | 1998-09-17 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
ATE256699T1 (de) | 1997-05-30 | 2004-01-15 | Celltech Therapeutics Ltd | Entzündungshemmende tyrosin-derivate |
GB9722287D0 (en) | 1997-10-22 | 1997-12-17 | Pfizer Ltd | Compounds useful in therapy |
GB9805520D0 (en) | 1998-03-17 | 1998-05-13 | Zeneca Ltd | Chemical compounds |
WO1999055661A1 (en) | 1998-04-24 | 1999-11-04 | Proteus Molecular Design Limited | Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
GB9812523D0 (en) | 1998-06-10 | 1998-08-05 | Angeletti P Ist Richerche Bio | Peptide inhibitors of hepatitis c virus ns3 protease |
DE19845407B4 (de) | 1998-10-02 | 2012-06-28 | Arysta LifeScience North America Corp.(n.d.Ges.d.Staates Californien) | Selektive Herbizide auf Basis eines substituierten Phenylsulfonylaminocarbonyl-triazolinons |
IT1303249B1 (it) | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
US6117870A (en) | 1998-11-12 | 2000-09-12 | Fujirebio Kabushiki Kaisha | Cyclic amide derivatives |
UA74781C2 (en) | 1999-04-02 | 2006-02-15 | Abbott Lab | Antiinflammatory and immumosuppressive compounds inhibiting cell adhesion |
IL145922A0 (en) | 1999-04-28 | 2002-07-25 | Aventis Pharma Gmbh | Di-aryl acid derivatives as ppar receptor ligands |
CA2374820A1 (en) | 1999-05-24 | 2000-11-30 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
MXPA02000722A (es) | 1999-07-21 | 2002-07-22 | Wyeth Corp | Antagonistas biciclicos selectivos para la integrina alfav beta3. |
JP4556371B2 (ja) | 1999-09-30 | 2010-10-06 | 三菱化学株式会社 | アシルスルホンアミド誘導体 |
JP4491866B2 (ja) | 1999-09-30 | 2010-06-30 | 三菱化学株式会社 | アシルスルホンアミド誘導体 |
IL139457A0 (en) | 1999-11-08 | 2001-11-25 | Pfizer | Compounds for the treatment of female sexual dysfunction |
GB2356139A (en) | 1999-11-15 | 2001-05-16 | Bayer Ag | Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases |
KR100704718B1 (ko) | 1999-12-27 | 2007-04-09 | 바이엘 코포레이션 | 설포닐아미노카보닐 트리아졸리논 염의 제조방법 |
US6160125A (en) * | 1999-12-27 | 2000-12-12 | Bayer Corporation | Process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent |
DE60114994T2 (de) | 2000-02-04 | 2006-08-03 | Portola Pharmaceuticals, Inc., South San Francisco | Blutplättchen-adp-rezeptor-inhibitoren |
US6180125B1 (en) * | 2000-02-18 | 2001-01-30 | Colgate-Palmolive Company | Low tack cosmetic composition sticks |
TWI288745B (en) | 2000-04-05 | 2007-10-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
DE10031825A1 (de) | 2000-06-30 | 2002-01-10 | Bayer Ag | Selektive Herbizide auf Basis von Arylsulfonylaminocarbonyltriazolinonen |
AU2001267878A1 (en) | 2000-07-05 | 2002-01-14 | Ajinomoto Co. Inc. | Hypoglycemics |
CA2369967A1 (en) | 2001-02-12 | 2002-08-12 | Joseph Anthony Cornicelli | Methods of treating nuclear factor-kappa b mediated diseases and disorders |
-
2002
- 2002-10-03 AR ARP020103736A patent/AR037097A1/es unknown
- 2002-10-04 CN CNB028197577A patent/CN100509774C/zh not_active Expired - Fee Related
- 2002-10-04 BR BR0213131-5A patent/BR0213131A/pt not_active IP Right Cessation
- 2002-10-04 IL IL16078602A patent/IL160786A0/xx unknown
- 2002-10-04 KR KR1020097024161A patent/KR20090123988A/ko not_active Application Discontinuation
- 2002-10-04 CA CA002458453A patent/CA2458453A1/en not_active Abandoned
- 2002-10-04 WO PCT/EP2002/011140 patent/WO2003031397A1/en active Application Filing
- 2002-10-04 MX MXPA04003236A patent/MXPA04003236A/es active IP Right Grant
- 2002-10-04 NZ NZ532072A patent/NZ532072A/en not_active IP Right Cessation
- 2002-10-04 AU AU2002350490A patent/AU2002350490B2/en not_active Ceased
- 2002-10-04 PE PE2002000993A patent/PE20030548A1/es not_active Application Discontinuation
- 2002-10-04 US US10/490,464 patent/US7482462B2/en not_active Expired - Fee Related
- 2002-10-04 PL PL02367411A patent/PL367411A1/xx not_active Application Discontinuation
- 2002-10-04 HU HU0401687A patent/HUP0401687A3/hu unknown
- 2002-10-04 JP JP2003534381A patent/JP4390559B2/ja not_active Expired - Fee Related
- 2002-10-04 EP EP10159985A patent/EP2228364A1/en not_active Withdrawn
- 2002-10-04 EP EP02785159A patent/EP1436253A1/en not_active Withdrawn
- 2002-10-04 KR KR1020047004906A patent/KR100952770B1/ko not_active IP Right Cessation
-
2004
- 2004-05-05 CO CO04041364A patent/CO5570700A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2005504843A (ja) | 2005-02-17 |
PE20030548A1 (es) | 2003-07-07 |
CO5570700A2 (es) | 2005-10-31 |
US20050059712A1 (en) | 2005-03-17 |
EP1436253A1 (en) | 2004-07-14 |
BR0213131A (pt) | 2004-09-21 |
KR100952770B1 (ko) | 2010-04-14 |
HUP0401687A2 (hu) | 2004-11-29 |
CA2458453A1 (en) | 2003-04-17 |
JP4390559B2 (ja) | 2009-12-24 |
CN1564811A (zh) | 2005-01-12 |
IL160786A0 (en) | 2004-08-31 |
KR20090123988A (ko) | 2009-12-02 |
EP2228364A1 (en) | 2010-09-15 |
CN100509774C (zh) | 2009-07-08 |
MXPA04003236A (es) | 2004-07-23 |
NZ532072A (en) | 2007-02-23 |
HUP0401687A3 (en) | 2008-06-30 |
KR20050033509A (ko) | 2005-04-12 |
PL367411A1 (en) | 2005-02-21 |
WO2003031397A1 (en) | 2003-04-17 |
AU2002350490B2 (en) | 2006-07-27 |
US7482462B2 (en) | 2009-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR037097A1 (es) | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento | |
AR072906A1 (es) | Nucleosidos modificados utiles como antivirales | |
CO5650164A2 (es) | Hetrociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6 | |
AR040047A1 (es) | 1-(aminoalquil)-3-sulfonilazaindoles como ligandos de la 5-hidroxitriptamina-6 | |
AR038703A1 (es) | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 | |
AR059339A1 (es) | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene | |
ES2530943T3 (es) | Derivados de la cromenona con actividad antitumoral | |
AR032361A1 (es) | Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos | |
AR065811A1 (es) | Derivados de 2-amino-4h-imidazol-4-ona,composiciones farmaceuticas que los contienen y usos para el tratamiento de la enfermedad de alzheimer y otros trastornos neurodegenerativos. | |
CO5251381A1 (es) | Derivados de adamantano, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
AR051092A1 (es) | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa | |
AR083367A1 (es) | Compuestos de tipo quinazolinona como antagonistas de crth | |
AR061974A1 (es) | Derivados de pirimidina como inhibidores de alk, composiciones farmaceuticas y procesos de obtencion | |
AR057986A1 (es) | Compuesto heterociclico y su uso farmaceutico | |
BRPI0707491B8 (pt) | compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas | |
AR051094A1 (es) | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa | |
AR067443A1 (es) | Derivados heterociclicos de n-benziloxazolidinonas potenciadores de receptores de glutamato mglur2, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento de trastornos del sistema nervioso central | |
AR049399A1 (es) | Difenilimidazopirimidina e -imidazol aminas como inhibidores de b-secretasa y metodo de obtencion de los mismos | |
AR081848A1 (es) | Inhibidores de la proteina ns5a del vhc | |
AR040566A1 (es) | Derivados de 1-heterociclilalquil 3- sulfonilazaindol o azaindazol como ligandos de 5 hidroxitriptamina-6 | |
AR015765A1 (es) | Dihidropirimidinas 2 heterociclicamente sustituidas, proceso para su preparacion, medicamentos que los contienen, proceso para la preparacion de los mismosuso de dichos dihidropirimidinas para la preparacion de un medicamento. | |
AR076723A1 (es) | Compuestos que contienen acido carboxilico, derivados de los mismos y su uso como moduladores de la gamma secretasa | |
AR080865A1 (es) | Derivados de espirotetrahidronaftaleno, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos para tratar enfermedades neurodegenerativas,tal como alzheimer. | |
AR036042A1 (es) | Derivados aralquilsufonil-3-(pirrol-2-ilmetiliden)-2-indolinona, sus composiciones farmaceuticas y metodo para la modulacion de la actividad catalitica de una proteina quinasa | |
AR070992A1 (es) | Derivados de 2-aril-6-fenil-inidazo[1,2a]piridinas, su preparacion, composiciones farmaceuticas y su uso en enfermedades que implican los receptores nucleares nurr-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |